Emicizumab is well tolerated and effective in people with congenital haemophila A regardless of age severity of disease or inhibitor status a scoping review

Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

WILEY-BLACKWELL

Abstract

Description

Keywords

Citation

WOS

Endorsement

Review

Supplemented By

Referenced By